Last updated: March 25, 2024
Sponsor: Orlando Health, Inc.
Overall Status: Active - Recruiting
Phase
N/A
Condition
Gastric Cancer
Colon Cancer
Stomach Cancer
Treatment
Endoscopic ultrasound examination
Clinical Study ID
NCT06340620
24.017.01
Ages 18-100 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Age ≥ 18 years
- Any patient undergoing EUS examination for evaluation of the pancreas, bile duct,mediastinal or intraabdominal lymph nodes, or luminal lesions in the esophagus,stomach, duodenum or colon.
Exclusion
Exclusion Criteria:
- Age < 18 years.
- Unable to obtain consent for the procedure from either the patient or LAR.
- Intrauterine pregnancy.
Study Design
Total Participants: 140
Treatment Group(s): 1
Primary Treatment: Endoscopic ultrasound examination
Phase:
Study Start date:
March 25, 2024
Estimated Completion Date:
December 31, 2027
Study Description
Connect with a study center
Orlando Health
Orlando, Florida 32806
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.